Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Abstract Text:

BACKGROUND.: To the authors' knowledge, genetic abnormalities in early-stage chronic lymphocytic leukemia (CLL) have not been examined fully. Single nucleotide polymorphism (SNP) genomic array (SNP-chip) is a new tool that can detect copy number changes and uniparental disomy (UPD) over the entire genome with very high resolution. METHODS.: The authors performed SNP-chip analysis on 56 samples from patients with early-stage, untreated CLL. To validate the SNP-chip data, fluorescence in situ hybridization (FISH) analysis was performed at selected sites. Expression levels of ZAP-70 and the mutational status of immunoglobulin heavy-chain gene also were examined. RESULTS.: SNP-chip analysis easily detected nearly all changes that were identified by FISH, including trisomy 12, deletion of TP53 (17p13), deletion of ATM (11q22), and deletion of 13q14. Only 10 of 56 CLL samples (18%) had no genomic abnormalities. Excluding the 4 common abnormalities mentioned above, 25 CLL samples (45%) had a total of 45 copy number changes detected by SNP-chip analysis. Four samples had 6q deletion at 6q21 that involved the AIM1 gene. UPD was detected in 4 samples; 2 samples involved whole chromosome 13 resulting in homozygous deletion of micro-RNA-15a (miR-15a)/miR-16-1. CLL samples with deletion of 13q14 and trisomy 12 were mutually exclusive. CONCLUSIONS.: Genetic abnormalities, including whole chromosome 13 UPD, are very common events in early-stage CLL. SNP-chip analysis can detect small genetic abnormalities in CLL and may be able to support or even supplant FISH and cytogenetics. Cancer 2008. (c) 2008 American Cancer Society.

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer

VOLUME: 112

Page Numbers: 1296-305

Journal Abbreviation: Cancer

ISSN: 0008-543X

DAY: 15

MONTH: Mar

YEAR: 2008

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 374236

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.

AFFILIATION: Department of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia Related Publications

• 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
• A Role for the PPARgamma in Cancer Therapy.
• ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.
• Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders.
• Advances in the treatment of acute myeloid leukemia: from chromosomal aberrations to biologically targeted therapy.
• CYR61: a new measure of lung cancer outcome.
• Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.
• Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells.
• Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme.
• Functional domains of CCN1 (Cyr61) regulate breast cancer progression.
• Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
• Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells.
• Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.
• Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBP{beta}-deficient hematopoietic cells.
• In vitro and in vivo evaluation and a case report of intense nanosecond pulsed electric field as a local therapy for human malignancies.
• KLF6: mutational analysis and effect on cancer cell proliferation.
• Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway.
• Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
• Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
• PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells.
• Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells.
• RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation.
• Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues.
• SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells.
• The clock gene Per2 links the circadian system to the estrogen receptor.
• The role of circadian regulation in cancer.
• Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.
• Vitamin D analogs and breast cancer.
• Vitamin D compounds and myelodysplastic syndrome.
• [On the pathogenesis, clinical aspects and differential diagnosis of symptomatic aplastic forms of anemia with a final picture of leukosis.]